Marie Christine Falcou

Validation and Limitations of Use of a Breast Cancer Nomogram Predicting the Likelihood of Non–Sentinel Node Involvement After Positive Sentinel Node Biopsy

S. Alran, Yann De Rycke, Virginie Fourchotte et al. · Annals of Surgical Oncology · 2007 · 147 citations

Medicine, Oncology, Breast Oncology +13

Concordant analysis of KRAS status in primary colon carcinoma and matched metastasis.

Pascale Mariani, Marick Laé, Armelle Degeorges et al. · PubMed · 2010 · 37 citations

Medicine, Cancer Biology, Oncology +17

Sentinel Lymph Node Detection for Breast Cancer: Which Patients Are Best Suited for the Patent Blue Dye Only Method of Identification?

Claude Nos, Paul Fr�neaux, Sandrine Guilbert et al. · Annals of Surgical Oncology · 2001 · 33 citations

Medicine, Oncology, Pathology +17

Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome

Pascale This, Anne de la Rochefordière, Alexia Savignoni et al. · Familial Cancer · 2012 · 17 citations

Medicine, Oncology, Risk Management +17